Microphysiological systems: analysis of the current status, challenges and commercial future

Area of Science:

• Biotechnology
• Drug Discovery
• Medical Diagnostics

Background:

• Microphysiological systems (MPS), also known as organs-on-a-chip, have seen significant growth in research and commercialization efforts over the last decade.
• These advanced in vitro models offer potential to revolutionize various biomedical fields.

Purpose of the Study:

• To review and analyze the current state of microphysiological systems technology.
• To describe the commercial advancements and market progress in the organs-on-a-chip field.
• To discuss the existing challenges and future commercial prospects of MPS.

Main Methods:

• Comprehensive literature review of recent publications in the field of microphysiological systems.
• Analysis of market trends, commercialization efforts, and industry reports.
• Synthesis of findings to assess the current status and future outlook.

Main Results:

• The field of MPS has experienced a substantial increase in publications and commercialization activities.
• Significant progress has been made in developing and applying these systems for drug discovery and diagnostics.
• Several challenges remain, but the commercial outlook for MPS is promising.

Conclusions:

• Microphysiological systems represent a rapidly evolving area with high potential for impact in drug discovery and personalized medicine.
• Continued innovation and strategic commercialization are key to overcoming current challenges and realizing the full potential of organs-on-a-chip technology.
• The future outlook for MPS is positive, with expectations of broader adoption and significant contributions to healthcare.